Critical Illness Polyneuropathy and Myopathy in the Intensive Care Unit

Overview

Journal Nat Rev Neurol

Specialty Neurology

Date 2009 Jul 7

PMID 19578344

Citations 36

Authors

Wolfgang Zink

Rainer Kollmar

Stefan Schwab

Affiliations

Soon will be listed here.

Abstract

Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are major complications that occur in severely ill patients who require intensive care treatment. CIP and CIM affect the limb and respiratory muscles, and, as a consequence, they characteristically complicate weaning from the ventilator, increase the length of stay on the intensive care unit, and prolong physical rehabilitation. The basic pathophysiology of both disorders is complex and involves metabolic, inflammatory and bioenergetic alterations. It is unclear at present whether CIP and CIM are distinct entities, or whether they just represent different 'organ' manifestations of a common pathophysiological mechanism. This article provides an overview of the clinical and diagnostic features of CIP and CIM and discusses current pathophysiological and therapeutic concepts relating to these neuromuscular disorders.

Citing Articles

Early detection of low QRS voltage and its association with mortality in patients with sepsis.

Na S, Ko R, Chung C, Yang J, Oh D, Lee S Sci Rep. 2024; 14(1):16066.

PMID: 38992092 PMC: 11239899. DOI: 10.1038/s41598-024-66612-x.

Patterns of Unwanted Biological and Technical Expression Variation Among 49 Human Tissues.

Nieuwenhuis T, Giles H, Arking J, Patil A, Shi W, McCall M Lab Invest. 2024; 104(6):102069.

PMID: 38670317 PMC: 11726374. DOI: 10.1016/j.labinv.2024.102069.

THE EFFECT OF IN-BED LEG CYCLING EXERCISES ON MUSCLE STRENGTH IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED WEAKNESS: A SINGLE-CENTER RETROSPECTIVE STUDY.

Shinohara A, Kagaya H, Komura H, Ozaki Y, Teranishi T, Nakamura T J Rehabil Med Clin Commun. 2024; 6:18434.

PMID: 38188901 PMC: 10768111. DOI: 10.2340/jrmcc.v6.18434.

Lower serum cholesterol levels as a risk factor for critical illness polyneuropathy: a matched case-control study.

Zulehner G, Seidel S, Polanz A, Schorgenhofer C, Rommer P, Merrelaar M Sci Rep. 2023; 13(1):20405.

PMID: 37990042 PMC: 10663605. DOI: 10.1038/s41598-023-47232-3.

Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessments.

Balloff C, Bandlow C, Bernhard M, Brandenburger T, Bludau P, Elben S Sci Rep. 2023; 13(1):19619.

PMID: 37949882 PMC: 10638293. DOI: 10.1038/s41598-023-46124-w.

References

Needham D . Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA. 2008; 300(14):1685-90. DOI: 10.1001/jama.300.14.1685. View

De Letter M, van Doorn P, Savelkoul H, Laman J, Schmitz P, Op de Coul A . Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol. 2000; 106(1-2):206-13. DOI: 10.1016/s0165-5728(99)00252-0. View

Nanas S, Kritikos K, Angelopoulos E, Siafaka A, Tsikriki S, Poriazi M . Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand. 2008; 118(3):175-81. DOI: 10.1111/j.1600-0404.2008.00996.x. View

Norman H, Kandala K, Kolluri R, Zackrisson H, Nordquist J, Walther S . A porcine model of acute quadriplegic myopathy: a feasibility study. Acta Anaesthesiol Scand. 2006; 50(9):1058-67. DOI: 10.1111/j.1399-6576.2006.01105.x. View

Hund E . Myopathy in critically ill patients. Crit Care Med. 1999; 27(11):2544-7. DOI: 10.1097/00003246-199911000-00036. View

Schweickert W, Hall J . ICU-acquired weakness. Chest. 2007; 131(5):1541-9. DOI: 10.1378/chest.06-2065. View

Khan J, Harrison T, Rich M . Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin. 2008; 24(1):165-77, x. PMC: 2268032. DOI: 10.1016/j.ccc.2007.10.004. View

Kerbaul F, Brousse M, Collart F, Pellissier J, Planche D, Fernandez C . Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care. 2004; 8(6):R358-66. PMC: 1065049. DOI: 10.1186/cc2925. View

Tiao G, Hobler S, Wang J, Meyer T, Luchette F, Fischer J . Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest. 1997; 99(2):163-8. PMC: 507782. DOI: 10.1172/JCI119143. View

10.

Acharyya S, Ladner K, Nelsen L, Damrauer J, Reiser P, Swoap S . Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004; 114(3):370-8. PMC: 484974. DOI: 10.1172/JCI20174. View

11.

Trojaborg W . Electrophysiologic techniques in critical illness-associated weakness. J Neurol Sci. 2006; 242(1-2):83-5. DOI: 10.1016/j.jns.2005.11.019. View

12.

Lacomis D, Campellone J . Critical illness neuromyopathies. Adv Neurol. 2002; 88:325-35. View

13.

Hermans G, de Jonghe B, Bruyninckx F, Van den Berghe G . Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2009; (1):CD006832. DOI: 10.1002/14651858.CD006832.pub2. View

14.

Lydon A, Martyn J . Apoptosis in critical illness. Int Anesthesiol Clin. 2003; 41(1):65-77. DOI: 10.1097/00004311-200341010-00006. View

15.

Tennila A, Salmi T, Pettila V, Roine R, Varpula T, Takkunen O . Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000; 26(9):1360-3. DOI: 10.1007/s001340000586. View

16.

Teener J, Rich M . Dysregulation of sodium channel gating in critical illness myopathy. J Muscle Res Cell Motil. 2006; 27(5-7):291-6. DOI: 10.1007/s10974-006-9074-5. View

17.

Rich M, Teener J, Raps E, Bird S . Muscle inexcitability in patients with reversible paralysis following steroids and neuromuscular blockade. Muscle Nerve. 1998; 21(9):1231-2. DOI: 10.1002/(sici)1097-4598(199809)21:9<1231::aid-mus21>3.0.co;2-t. View

18.

de Jonghe B, Bastuji-Garin S, Durand M, Malissin I, Rodrigues P, Cerf C . Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007; 35(9):2007-15. DOI: 10.1097/01.ccm.0000281450.01881.d8. View

19.

Hough C, Steinberg K, Thompson B, Rubenfeld G, Hudson L . Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med. 2008; 35(1):63-8. PMC: 2861487. DOI: 10.1007/s00134-008-1304-4. View

20.

Friedrich O, H A Fink R, Hund E . Understanding critical illness myopathy: approaching the pathomechanism. J Nutr. 2005; 135(7):1813S-1817S. DOI: 10.1093/jn/135.7.1813S. View